Literature DB >> 1987270

Mutations affecting antigen processing impair class II-restricted allorecognition.

T Cotner1, E Mellins, A H Johnson, D Pious.   

Abstract

Both exogenously derived and endogenously derived Ag generally require processing for their optimal binding and presentation by class I and class II major histocompatibility proteins. It is not known whether steps involved in Ag processing also affect the recognition of alloreactive T cells. We have recently described B cell mutants which have general defects in the processing and presentation of a variety of exogenous Ag to class II restricted T cells. In this report we have studied the ability of these processing mutants to stimulate a set of anti-DR3-specific alloreactive T cells clones. These processing/presentation mutants express normal MHC class II molecules, both in terms of primary sequence and cell surface abundance, but they appear unable to generate effective peptide-MHC complexes. When tested for their ability to stimulate MHC class II alloreactive T cell clones, only one of four T cell clones was stimulated by these mutants; the other three alloreactive T cell clones were not stimulated by either of two different mutants. Both of these mutants express normal levels of the accessory molecules, LFA-3 and ICAM-1. The inability of these mutants to stimulate three of four alloreactive clones indicates that the capacity to be recognized by many alloreactive T cells is linked to the Ag processing capacity of a stimulator cell.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987270

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway.

Authors:  M E Grigg; C W McMahon; S Morkowski; A Y Rudensky; A M Pullen
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

2.  The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

Authors:  C C Stebbins; G E Loss; C G Elias; A Chervonsky; A J Sant
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

3.  A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.

Authors:  E Mellins; P Cameron; M Amaya; S Goodman; D Pious; L Smith; B Arp
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

4.  Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.

Authors:  L Racioppi; F Ronchese; L A Matis; R N Germain
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.